Grants and Contributions:
Title:
Preclinical testing of a vaccine platform
Agreement Number:
973965
Agreement Value:
$204,000.00
Agreement Date:
May 15, 2021 - May 31, 2022
Description:
This project will validate a proprietary vaccine platform using a COVID-19 pilot study.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Surrey, British Columbia, CA V4A 4N2
Reference Number:
172-2021-2022-Q1-973965
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
732113931
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Amendment Date
Mar 31, 2022
Recipient's Legal Name:
Eyam Vaccines and Immunotherapeutics Ltd.
Federal Riding Name:
South Surrey--White Rock
Federal Riding Number:
59030
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: